Marie-Laure Crouch

Marie-Laure Crouch

Auto-generated profile, based on publicly available information

Marie-Laure Crouch

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MCMarie-Laure Crouch
Marie-Laure Crouch
GKGary Knowels
Gary Knowels
RSRudolph Stuppard
Rudolph Stuppard
NENolan G. Ericson
Nolan G. Ericson
JBJason H. Bielas
Jason H. Bielas
KSKaren L. Syrjala
Karen L. Syrjala
Fatigue is the symptom most commonly reported by long-term cancer survivors and is increasingly recognized as related to skeletal muscle dysfunction. Traditional chemotherapeutic agents can cause acute toxicities including cardiac and skeletal myopathies. To investigate the mechanism by which chemotherapy may lead to persistent skeletal muscle dysfunction, mature adult mice were injected with a single cyclophosphamide dose and evaluated for 6 weeks. We found that exposed mice developed a persistent decrease in treadmill running time compared to baseline (25.7±10.6 vs. 49.0±16.8 min, P = 0.0012). Further, 6 weeks after drug exposure, in vivo parameters of mitochondrial function remained below baseline including maximum ATP production (482.1 ± 48.6 vs. 696.2 ± 76.6, P = 0.029) and phosphocreatine to ATP ratio (3.243 ± 0.1 vs. 3.878 ± 0.1, P = 0.004). Immunoblotting of homogenized muscles from treated animals demonstrated a transient increase in HNE adducts 1 week after exposure that resolved by 6 weeks. However, there was no evidence of an oxidative stress response as measured by quantitation of SOD1, SOD2, and catalase protein levels. Examination of mtDNA demonstrated that the mutation frequency remained comparable between control and treated groups. Interestingly, there was evidence of a transient increase in NF-ĸB p65 protein 1 day after drug exposure as compared to saline controls (0.091±0.017 vs. 0.053±0.022, P = 0.033). These data suggest that continued impairment in muscle and mitochondria function in cyclophosphamide-treated animals is not linked to persistent oxidative stress and that alternative mechanisms need to be considered.

9 January 2021 in Journal of Cancer Survivorship
Verified
Journal Article
Closed access
PDF file
KNKristina Holmegaard Nørskov
Kristina Holmegaard Nørskov
JYJean C. Yi
Jean C. Yi
MCMarie-Laure Crouch
Marie-Laure Crouch
AFAllison Stover Fiscalini
Allison Stover Fiscalini
MFMary E. D. Flowers
Mary E. D. Flowers
KSKaren L. Syrjala
Karen L. Syrjala